BLOOMIN' BRANDS INC (BLMN)

US0942351083 - Common Stock

11.53  -0.42 (-3.51%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BLMN. BLMN was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. While BLMN is still in line with the averages on profitability rating, there are concerns on its financial health. BLMN has a valuation in line with the averages, but on the other hand it scores bad on growth.



6

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
Of the past 5 years BLMN 4 years were profitable.
In the past 5 years BLMN always reported a positive cash flow from operatings.

1.2 Ratios

BLMN has a Return On Assets of -0.15%. This is in the lower half of the industry: BLMN underperforms 63.91% of its industry peers.
BLMN has a Return On Equity of -2.18%. This is comparable to the rest of the industry: BLMN outperforms 48.87% of its industry peers.
The Return On Invested Capital of BLMN (8.45%) is better than 68.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLMN is above the industry average of 10.55%.
The last Return On Invested Capital (8.45%) for BLMN is well below the 3 year average (12.76%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROIC 8.45%
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.76%
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of BLMN has grown nicely.
Looking at the Operating Margin, with a value of 5.82%, BLMN is in line with its industry, outperforming 41.35% of the companies in the same industry.
In the last couple of years the Operating Margin of BLMN has grown nicely.
BLMN has a Gross Margin of 70.30%. This is amongst the best in the industry. BLMN outperforms 83.46% of its industry peers.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 70.3%
OM growth 3YN/A
OM growth 5Y11.58%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%

2

2. Health

2.1 Basic Checks

BLMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BLMN has been reduced compared to 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
BLMN has a better debt/assets ratio than last year.

2.2 Solvency

BLMN has an Altman-Z score of 1.22. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.22, BLMN perfoms like the industry average, outperforming 41.35% of the companies in the same industry.
BLMN has a Debt/Equity ratio of 4.54. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BLMN (4.54) is worse than 61.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACC1.03
WACC8.17%

2.3 Liquidity

BLMN has a Current Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, BLMN is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
BLMN has a Quick Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a Quick ratio of 0.22. This is amonst the worse of the industry: BLMN underperforms 93.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.22

1

3. Growth

3.1 Past

BLMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.59%.
BLMN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.33% yearly.
The Revenue has decreased by -0.55% in the past year.
Measured over the past years, BLMN shows a small growth in Revenue. The Revenue has been growing by 2.51% on average per year.
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y14.33%
EPS Q2Q%-52.27%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Sales Q2Q%-3.8%

3.2 Future

BLMN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.81% yearly.
BLMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.80% yearly.
EPS Next Y-37.1%
EPS Next 2Y-20.14%
EPS Next 3Y-10.33%
EPS Next 5Y-6.81%
Revenue Next Year-5.06%
Revenue Next 2Y-4.73%
Revenue Next 3Y-2.65%
Revenue Next 5Y-1.8%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 5.31.
Based on the Price/Earnings ratio, BLMN is valued cheaply inside the industry as 97.74% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.20. BLMN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 6.21, the valuation of BLMN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BLMN is valued cheaply inside the industry as 98.50% of the companies are valued more expensively.
BLMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 5.31
Fwd PE 6.21

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 96.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.39

4.3 Compensation for Growth

BLMN has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as BLMN's earnings are expected to decrease with -10.33% in the coming years.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-20.14%
EPS Next 3Y-10.33%

5

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 8.05%, which is a nice return.
The stock price of BLMN dropped by -28.40% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 2.95. BLMN pays more dividend than 97.74% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.05%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 21.41%!
BLMN has been paying a dividend for over 5 years, so it has already some track record.
BLMN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)21.41%
Div Incr Years1
Div Non Decr Years2

5.3 Sustainability

The earnings of BLMN are negative and hence is the payout ratio. BLMN will probably not be able to sustain this dividend level.
DP-1570.91%
EPS Next 2Y-20.14%
EPS Next 3Y-10.33%

BLOOMIN' BRANDS INC

NASDAQ:BLMN (12/23/2024, 9:51:53 AM)

11.53

-0.42 (-3.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners104.73%
Inst Owner Change4.41%
Ins Owners1.45%
Ins Owner Change0.39%
Market Cap978.21M
Analysts71.11
Price Target17.77 (54.12%)
Short Float %9.8%
Short Ratio4.47
Dividend
Industry RankSector Rank
Dividend Yield 8.05%
Dividend Growth(5Y)21.41%
DP-1570.91%
Div Incr Years1
Div Non Decr Years2
Ex-Date11-25 2024-11-25 (0.24)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.54%
Min EPS beat(2)-13.76%
Max EPS beat(2)0.68%
EPS beat(4)2
Avg EPS beat(4)-3.57%
Min EPS beat(4)-13.76%
Max EPS beat(4)6.55%
EPS beat(8)6
Avg EPS beat(8)1.95%
EPS beat(12)10
Avg EPS beat(12)3.63%
EPS beat(16)13
Avg EPS beat(16)27.59%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-2.62%
Max Revenue beat(2)-2.28%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-2.1%
Revenue beat(8)1
Avg Revenue beat(8)-2.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.77%
Revenue beat(16)4
Avg Revenue beat(16)-1.89%
PT rev (1m)-15.6%
PT rev (3m)-16.7%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)-50.9%
EPS NY rev (1m)-13.67%
EPS NY rev (3m)-14.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.72%
Revenue NY rev (1m)-0.66%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 5.31
Fwd PE 6.21
P/S 0.22
P/FCF N/A
P/OCF 3.66
P/B 4.04
P/tB N/A
EV/EBITDA 4.39
EPS(TTM)2.17
EY18.82%
EPS(NY)1.86
Fwd EY16.1%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)3.15
OCFY27.32%
SpS53.6
BVpS2.85
TBVpS-5.47
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROCE 10.23%
ROIC 8.45%
ROICexc 8.73%
ROICexgc 12.16%
OM 5.82%
PM (TTM) N/A
GM 70.3%
FCFM N/A
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.76%
ROIC(5y)N/A
ROICexc(3y)13.29%
ROICexc(5y)N/A
ROICexgc(3y)19.82%
ROICexgc(5y)N/A
ROCE(3y)15.46%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.04%
ROICexc growth 3YN/A
ROICexc growth 5Y6.3%
OM growth 3YN/A
OM growth 5Y11.58%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%
F-Score5
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF N/A
Debt/EBITDA 2.38
Cap/Depr 149.19%
Cap/Sales 6.51%
Interest Coverage 4.24
Cash Conversion 57.74%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.22
Altman-Z 1.22
F-Score5
WACC8.17%
ROIC/WACC1.03
Cap/Depr(3y)124.77%
Cap/Depr(5y)101.05%
Cap/Sales(3y)4.96%
Cap/Sales(5y)4.31%
Profit Quality(3y)127.3%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y14.33%
EPS Q2Q%-52.27%
EPS Next Y-37.1%
EPS Next 2Y-20.14%
EPS Next 3Y-10.33%
EPS Next 5Y-6.81%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Sales Q2Q%-3.8%
Revenue Next Year-5.06%
Revenue Next 2Y-4.73%
Revenue Next 3Y-2.65%
Revenue Next 5Y-1.8%
EBIT growth 1Y-26.4%
EBIT growth 3YN/A
EBIT growth 5Y14.38%
EBIT Next Year22.93%
EBIT Next 3Y6.5%
EBIT Next 5Y5.14%
FCF growth 1Y-113.24%
FCF growth 3Y59.81%
FCF growth 5Y21.11%
OCF growth 1Y-31.64%
OCF growth 3Y56.54%
OCF growth 5Y13.07%